Elissa S. Cote Email and Phone Number
Elissa S. Cote work email
- Valid
Elissa S. Cote personal email
A strategic-minded and results-driven senior executive with extensive commercial, operational, and transactional experience across a multitude of therapeutic areas including autoimmune/immunology, neurology/CNS, neuropsychiatry, infectious disease, oncology, critical care/pain, respiratory, nephrology, hepatology, gastroenterology. Provides executive-level leadership to industry-leading life sciences companies to develop and execute global enterprise and commercial strategies and brand priorities successfully. A visionary leader and exceptional communicator who has a multifaceted understanding of the drug development environment to increase company growth & progress in the industry.Select Leadership Experience: - Strategy Development: Corporate/Enterprise, Commercial, Brand & Franchise, Therapeutic & Disease Area.- Business Development and M&A: M&A Strategy and Execution (Buy-Side, Sell-Side), Final Term Negotiations, Deal Financing & Structuring, Diligence, Pre-Screening/Triage/Search & Evaluation.- Global Franchise Leadership (w/P&L): In-line P&L ownership >$500M gross annual revenue, 85% operating margin.- Global Strategic Marketing: New Product Planning, Global Brand Planning, Orphan Drug Development, Portfolio/Program Leadership, Market Access/Pricing Strategy, Health Economics and Outcomes (HEOR), Competitive Intelligence & Insights.- Orphan Drug Development Expertise: Rare & Ultra-Rare Orphan Drug Development & Program Leadership, BD&L /M&A.
Vistagen
View- Website:
- emergentbiosolutions.com
-
Chief Corporate Development OfficerVistagenWashington, Dc, Us
-
Chief Business AdvisorConfidential Healthcare & It Start-Up Feb 2022 - PresentLead business operations, sourcing, M&A, strategy, & marketing for start-up healthcare and IT company; revenue generating Q1 2023.
-
Strategic Advisor: Corporate Development And Strategy Lead (Consultant)Emergent Biosolutions 2023 - PresentGaithersburg, Maryland, UsLead corporate strategy and BD for mid-cap biopharmaceutical company. -
Chief Founding MemberChief May 2021 - Apr 2024New York, Ny, UsCHIEF founding member, Washington D.C. -
Chief Strategy And Business Development OfficerMallinckrodt Pharmaceuticals 2021 - 2022Dublin, Ireland, Ie• Responsible for BD and licensing transactions and strategic divestitures across global portfolio and in-line with enterprise strategy. Led end-to-end cross-functional process encompassing search and evaluation, triage, diligence, and final negotiations for opportunities across pipeline, in-line, and IP portfolios (U.S. and international, Canada, EU, Japan, China). • Led development of global corporate strategy (board deliverable) and long-term company vision across the ~1.2 billion enterprise (specialty products only); oversaw strategic projects related to franchise and asset optionality that were core to company vision and growth plan. • Responsible for alliance management function, with team overseeing up to six complex industry partnerships. -
Senior Vice President, Head Of Global Marketing & Commercial DevelopmentMallinckrodt Pharmaceuticals 2020 - 2021Dublin, Ireland, Ie• Established and led global marketing and commercial development organization to provide integrated support to R&D and commercial organizations in critical areas, including: new product planning (early and late-stage pipeline, lifecycle management), pre-commercialization strategy and launch planning (Phase 3). • Program lead for rare/orphan neurological asset across all integrated R&D, operations, commercial, and M&A functions and activities. • Developed enhanced commercial strategy and global annual brand plans across in-line portfolio while aligning U.S. and O-US strategies for assets across critical care business unit, immunology therapeutic area, and hepatology franchise.
-
Senior Vice President, Strategic Alliance Management & Head Of Gi CommercialMallinckrodt Pharmaceuticals 2018 - 2020Dublin, Ireland, Ie• Developed and oversaw therapeutic and disease area strategy in gastroenterology and led pre-commercialization and pre-launch activities for orphan GI/Oncology program, initially valued between $150-$300 million in peak revenue. • Led Phase 3 GI/Oncology product development for rare orphan program. Oversaw product’s progression through clinic including development, pre-commercialization and launch readiness.
-
Senior Vice President, Strategic Marketing And Analysis, Sucampo Pharmaceuticals, Inc.Mallinckrodt Pharmaceuticals 2015 - 2018Dublin, Ireland, Ie• Built and led core organizational functions for the company including global alliance management, global strategic marketing, corporate strategy, forecasting and analytics. • Supported BD assessments for evaluation and prioritization of M&A targets, including commercial assumptions and forecasting. Support extended to sourcing, evaluation, and diligence for all targets in support of BD lead. • Led corporate strategy and developed the company’s first enterprise strategy deliverable for the board of directors. • Responsible for global marketing function for two late-stage rare-disease orphan programs in neurology and gastrointestinal and oncology therapeutic areas.
-
Vice President, Marketing And External RelationsHistogenics 2013 - 2015Waltham, Ma, Us• Member of executive team responsible for successful initial public offering (IPO) of $70.1 million (gross proceeds). • Oversaw all strategic and pre-commercial, payer, and marketing activities for regenerative medicine candidate products in orthopedics space including strategic marketing/pre-commercial activities, revenue forecasts and valuations. • Core member of BD team, providing strategic and commercial input into M&A assessments and partnering opportunities.• Responsible for company public relations, corporate communications, and company branding.• Established and led investor relations (IR) function, including input into and execution of company investor strategy and targeting plan, roadshow and non-deal roadshow presentations, investor conferences, and analyst relationships. -
Director, Emerging Brands, Global Strategic MarketingMedimmune 2007 - 2013Gaithersburg, Maryland, Us• Oversaw strategic and global commercialization for several pre-clinical and early- and late-stage clinical compounds within MedImmune respiratory, inflammatory, and autoimmune (RIA) biologics portfolio. • Developed core disease area strategies for asthma, COPD, multiple sclerosis, systemic lupus erythematosus, and orphan diseases (neuromyelitis optica, scleroderma); supported commercial assessments and due diligence for large BD opportunities, including industry-leading co-development/co-commercialization partnerships. • Managed business analytics and forecasting group within MedImmune’s commercial organization; provided short-term and long-term forecast projections for in-line products within the company’s infectious disease franchise. -
Senior ManagerAccenture 1996 - 2007Dublin 2, IeManaged strategic planning, process and IT implementations, and tactical execution of large, multimillion-dollar strategic and IT projects across key industries. Participated in and led BD proposal development and competitive bidding process for key prospective and current clients. Successfully executed projects from over $1 million to $30 million in revenue.
Elissa S. Cote Education Details
-
Columbia Business SchoolM&A Business Certification -
Union CollegePolitical Science
Frequently Asked Questions about Elissa S. Cote
What company does Elissa S. Cote work for?
Elissa S. Cote works for Vistagen
What is Elissa S. Cote's role at the current company?
Elissa S. Cote's current role is Chief Corporate Development Officer.
What is Elissa S. Cote's email address?
Elissa S. Cote's email address is el****@****-us.com
What schools did Elissa S. Cote attend?
Elissa S. Cote attended Columbia Business School, Union College.
Who are Elissa S. Cote's colleagues?
Elissa S. Cote's colleagues are Solomon T. Negussie, Olena Rudenko, David Dilley, Adrianna Gray, James Bourne, Nicole Clark, Domonique Traylor.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial